Vivo Capital plans to acquire Dutscher, a leading European distributor of laboratory supplies, marking its first investment in Europe as part of an expansion strategy in the healthcare sector.

Target Information

Dutscher, founded in 1982 and headquartered in Brumath, near Strasbourg, is a leading European distributor of laboratory consumables and equipment for research and development. The company achieved a revenue exceeding €400 million in 2025, showcasing an average organic growth rate of 7% per year. With over 1,100 employees, Dutscher has established itself as a primary pan-European platform in its sector, generating more than 50% of its revenue outside of France. The company's extensive catalogue boasts over one million stock-keeping units (SKUs) and caters to more than 25,000 customers.

Under LBO France’s ownership, which began in 2020, Dutscher has fortified its European positioning through 13 acquisitions across various countries, including France, the UK, Ireland, Scandinavia, and the Baltic States. This strategic expansion has been bolstered by significant investments, including the establishment of three new warehouses in France, the UK, and Spain, enhancing the Group’s leadership in the European market.

Industry Overview in France

The laboratory supplies industry in France is a crucial component of the broader healthcare and life sciences sector. It serves a range of markets, including biotechnology, pharmaceuticals, and clinical resear

View Source

Similar Deals

BC Partners, Bpifrance Biogaran

2026

Buyout Generic Pharmaceuticals France
SK Capital Partners LISI Group's Medical division

2025

Buyout Medical Equipment, Supplies & Distribution (NEC) France
Asker Healthcare Group Finmed SAS

2025

Buyout Medical Equipment, Supplies & Distribution (NEC) France
Asker Healthcare Groupe FINMED

2025

Buyout Advanced Medical Equipment & Technology (NEC) France
Sanofi DR-0201

2025

Buyout Proprietary & Advanced Pharmaceuticals France
Sanofi Dren Bio, Inc.

2025

Buyout Proprietary & Advanced Pharmaceuticals France

Vivo Capital

invested in

Dutscher

in 2026

in a Buyout deal

Disclosed details

Revenue: $400M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert